Sulfamethoxazole Prices

Sulfamethoxazole Prices June 2023

In the second quarter of 2023, the price of sulfamethoxazole in the United States reached 14650 USD/MT by June. Similarly, in China, the sulfamethoxazole prices hit 16475 USD/MT in the same month. Germany also saw sulfamethoxazole prices reaching 21250 USD/MT during Q2 2023. 

Sulfamethoxazole Price Trend, Market Analysis, and News

IMARC’s newly published report, titled “Sulfamethoxazole Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of sulfamethoxazole pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.

It encompasses an in-depth review of spot price of sulfamethoxazole at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of sulfamethoxazole price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

The report examines the elements influencing sulfamethoxazole price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.

Sulfamethoxazole Market Analysis

The global sulfamethoxazole market size reached US$ 28.3 Million in 2023. By 2032, IMARC Group expects the market to reach US$ 37.9 Million, at a projected CAGR of 3.30% during 2023-2032.

The increasing prevalence of bacterial infections represent one of the key factors driving the growth of the sulfamethoxazole market. According to research published in the National Library of Medicine, more than 94 million Europeans complain of uncomfortable skin sensations like itching, burning, or dryness. The most frequently reported conditions were fungal skin infections (8.9%), acne (5.4%), and atopic dermatitis or eczema (5.5%). Alopecia, acne, eczema, and rosacea were more common in women, whereas men were more likely to suffer from psoriasis and sexually transmitted infections (STIs). Moreover, the rising instances of chronic ailments represents another major growth-inducing factor. For instance, the estimated prevalence of asymptomatic bacteriuria in women with diabetes is 26% compared to 6% in non-diabetic females. Patients with diabetes are also at increased risk of developing both acute cystitis and pyelonephritis. UTIs are common in patients who had renal transplantation, with retrospective cohort studies showing an incidence between 47% and 75%. In addition to this, as per the study report, urinary tract infections are highly prevalent in patients with type 2 diabetes. Besides this, the rising incidence of tuberculosis in North America is a pivotal factor in driving the growth of the sulfamethoxazole as it is used as a potential medicine to treat drug-resistant tuberculosis. For instance, during 2021, a total of 7,860 TB cases were provisionally reported to CDC’s National Tuberculosis Surveillance System (NTSS) by the 50 U.S. states and the District of Columbia (DC). National incidence of reported TB (cases per 100,000 persons) rose 9.4% during 2021 (2.37) compared with that in 2020 (2.16) but remained 12.6% lower than the rate during 2019 (2.71). During 2021, TB incidence increased among both U.S.-born and non–U.S.-born persons. Furthermore, the accessibility of healthcare infrastructure in emerging markets is catalyzing the demand for antibiotics, including sulfamethoxazole which, in turn, is contributing to the growth of the market.

Sulfamethoxazole News

The report covers the latest developments, updates, and trends impacting the global sulfamethoxazole market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in sulfamethoxazole production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the sulfamethoxazole price trend.

Product Description

Sulfamethoxazole is a sulfonamide antibiotic and is often used in conjunction with trimethoprim referred to as co-trimoxazole. This drug belongs to the sulfonamide class of drugs and is active against several bacteria, including gram positive, as well as gram negative. Sulfamethoxazole is composed of sulfonamide group that inhibits bacterial folic acid synthesis, which is essential for DNA synthesis and cell division. It is mainly prescribed for treating bacterial infections of the urinary system, respiratory tract infections, such as bronchitis, and Pneumocystis pneumonia in immunocompromised patients. The drug comes in different forms like tablets, liquid suspensions, and injectables to ease its administrative in various practice areas. The effectiveness of sulfamethoxazole and its ability to cover a wide spectrum of bacteria make it an important part of the antibiotic armament, especially in situations where the organisms are already resistant to other antibiotics.

Regional Coverage

The report provides a detailed analysis of the sulfamethoxazole market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the sulfamethoxazole price trend.

Global Sulfamethoxazole Price

The report offers a holistic view of the global sulfamethoxazole pricing trends in the form of sulfamethoxazole price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price of sulfamethoxazole but also provides insights into historical price trends, enabling stakeholders to understand past fluctuations and their underlying causes.

The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed sulfamethoxazole demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.

Europe Sulfamethoxazole Price

European sulfamethoxazole prices are examined, highlighting the market-specific influences in the region, such as stringent environmental regulations, the competitive landscape, and import-export imbalances that significantly affect pricing structures.

This analysis can be extended to include detailed sulfamethoxazole price information for a comprehensive list of countries.

North America Sulfamethoxazole Price

The analysis of sulfamethoxazole prices in North America delves into the regional industry dynamics, encompassing the impact of local production capacities and the trade flows between North America and other significant global markets.

Specific sulfamethoxazole historical data within the United States and Canada can also be provided.

Middle East and Africa Sulfamethoxazole Price

The report explores the sulfamethoxazole pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on sulfamethoxazole prices for countries can also be provided.

Asia Pacific Sulfamethoxazole Price

The sulfamethoxazole pricing trends in Asia Pacific are examined, reflecting the role of the region as a major global production hub and consumer market, with price dynamics heavily influenced by supply chain efficiencies, regional demand surges, and policy shifts in major economies.

This sulfamethoxazole price analysis can be expanded to include a comprehensive list of countries within the region.

Latin America Sulfamethoxazole Price

The analysis of sulfamethoxazole prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Report Coverage

Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of sulfamethoxazole pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
• The study examines factors affecting sulfamethoxazole price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The sulfamethoxazole price charts ensure our clients remain at the forefront of the industry.